Johnson & Johnson to pay $5.5 billion in talc cancer lawsuits

Johnson & Johnson will pay $5.5 billion in settlements to plaintiffs who claim the company's talc-based products caused ovarian cancer, the company announced. In 2023, Johnson & Johnson discontinued the global sale of its talc-based baby powder, although the company maintains that studies have proven the safety of talc.